R&D Platform

Our robust product portfolio is underpinned by our fully-integrated end-to-end platform with capabilities ranging from drug discovery and development to manufacturing and commercialization.

Bio-Thera has developed comprehensive technologies for antibody drug development, covering the entire development process from antibody discovery to engineering and process development. Our platform is applicable to a wide range of antibody formats such as mAbs, ADCs and bispecific antibodies. These technologies are complementary to each other, providing us with the flexibility and compatibility to precisely engineer and develop a steady stream of highly differentiated fit-for-purpose antibody candidates in a cost-effective manner.